Join to View Full Profile
9500 Euclid AveCleveland, OH 44195
Phone+1 216-444-6833
Fax+1 216-444-9464
Dr. Geiger is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
UPMC Medical EducationFellowship, Hematology and Medical Oncology, 2013 - 2016
Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 2010 - 2013
Wright State University Boonshoft School of MedicineClass of 2010
Certifications & Licensure
OH State Medical License 2016 - 2027
PA State Medical License 2013 - 2016
MN State Medical License 2011 - 2013
Publications & Presentations
PubMed
- Amivantamab in recurrent/metastatic HNSCC after checkpoint inhibitor and chemotherapy: pivotal results from the phase 1b/2 OrigAMI-4 study.Barbara Burtness, Ari J Rosenberg, Benoit Calderon, Sun Min Lim, Muh-Hwa Yang
Journal of Clinical Oncology. 2026-05-31 - Bridging the Gap: What We Can Learn From LEAP-010 in Recurrent/Metastatic Head and Neck Cancer.Jenny Xiang, Jessica L Geiger
Journal of Clinical Oncology. 2026-04-20 - Contemporary Management of Malignancies of the Parotid Gland: A State-of-the-Art Review.Anthony Tang, Vanessa Helou, Shaum S Sridharan, Renata Ferrarotto, Jessica L Geiger
Otolaryngology--Head and Neck Surgery. 2026-04-01
Lectures
- KEYNOTE-630: Phase 3 study of adjuvant pembrolizumab versus placebo in patients with high-risk, locally advanced cutaneous squamous cell carcinoma.ASCO Annual Meeting 2019 - Chicago, IL - 6/3/2019
- Outcomes of post-operative treatment with concurrent systemic therapy and radiotherapy (RT) in intermediate (INT) risk resected oral cavity squamous cell carcinoma (OC...ASCO Annual Meeting 2019 - Chicago, IL - 5/31/2019
- Outcomes of post-operative treatment with concurrent chemoradiotherapy (CRT) in high risk resected oral cavity squamous cell carcinoma (OCSCC): A multi-institutional c...ASCO Annual Meeting 2019 - Chicago, IL - 6/1/2019
Press Mentions
Adjuvant Immunotherapy in High-Risk Cutaneous Squamous Cell CarcinomaJune 2nd, 2025- Remembering Famed Film Critic Roger Ebert 10 Years After Passing from Cancer: The Incredible Advancements in Head and Neck Cancer TreatmentApril 5th, 2023
- Tennis Legend Martina Navratilova, 66, Was About to Adopt a Child with Her ‘Real Housewives’ Love Before Cancer Hit AgainMarch 17th, 2023
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
